RELMADA THERAPEUTICS, INC. (RLMD) Operating Income (Loss) USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Relmada Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2024.
  • Relmada Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$23 M, a 18.3% increase year-over-year.
  • Relmada Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$98.5 M, a 34.8% increase year-over-year.
  • Relmada Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$104 M, a 35.7% increase from 2022.
  • Relmada Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$161 M, a 28.3% decline from 2021.
  • Relmada Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$126 M, a 107% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$98.5 M -$23 M +$5.17 M +18.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$104 M -$26.8 M +$11.9 M +30.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$116 M -$22.7 M +$16 M +41.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$132 M -$26 M +$19.5 M +42.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$151 M -$28.2 M +$10.1 M +26.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$161 M -$38.7 M -$4.52 M -13.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$157 M -$38.7 M +$3.92 M +9.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$161 M -$45.5 M -$19.1 M -72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$142 M -$38.3 M -$15.9 M -70.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$126 M -$34.2 M -$13.3 M -63.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$112 M -$42.7 M -$25.5 M -148% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$87 M -$26.5 M -$13.7 M -107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$73.3 M -$22.4 M -$12.4 M -125% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$60.8 M -$20.9 M -$16.4 M -358% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$44.5 M -$17.2 M -$13.5 M -363% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$31 M -$12.8 M -$8.62 M -208% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$22.4 M -$9.97 M -$7.27 M -269% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$15.1 M -$4.56 M -$1.09 M -31.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$14 M -$3.71 M -$1.3 M -53.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$12.7 M -$4.14 M -$2.21 M -114% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$10.5 M -$2.7 M -$152 K -5.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$10.4 M -$3.48 M -$2.02 M -139% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-13
Q3 2018 -$8.35 M -$2.41 M -$1.43 M -146% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$6.92 M -$1.93 M -$147 K -8.26% Apr 1, 2018 Jun 30, 2018 10-KT 2020-03-26
Q1 2018 -$6.77 M -$2.55 M -$267 K -11.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.5 M -$1.46 M +$79.8 K +5.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 -$6.58 M -$981 K +$636 K +39.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$7.22 M -$1.78 M +$1.33 M +42.8% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-28
Q1 2017 -$8.55 M -$2.28 M +$464 K +16.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$9.02 M -$1.54 M +$4.19 M +73.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-12
Q3 2016 -$13.2 M -$1.62 M +$3.01 M +65.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$16.2 M -$3.12 M +$1.3 M +29.4% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 -$17.5 M -$2.75 M +$1.83 M +40% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$19.3 M -$5.72 M -$1.34 M -30.5% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 -$18 M -$4.63 M -$907 K -24.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$17.1 M -$4.41 M Apr 1, 2015 Jun 30, 2015 10-K 2016-09-09
Q1 2015 -$4.58 M -$3.87 M -543% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$4.38 M +$670 K +13.3% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 -$3.72 M -$3.24 M -673% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 -$6.27 M -$712 K -$111 K -18.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$6.16 M -$5.06 M -$5.05 M -55944% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 -$1.11 M -$482 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$19.5 K -$17 K -685% Mar 1, 2013 May 31, 2013 10-Q 2013-07-12
Q1 2013 -$601 K -$600 K -119367% Jan 1, 2013 Mar 31, 2013 8-K 2014-05-27
Q4 2012 -$9.02 K* Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-13
Q2 2012 -$2.48 K* Mar 1, 2012 May 31, 2012 10-Q 2013-07-12
Q1 2012 -$503* Dec 1, 2011 Feb 29, 2012 10-Q 2013-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.